|
1
|
Wilde B, van Paassen P, Witzke O and
Tervaert JW: New pathophysiological insights and treatment of
ANCA-associated vasculitis. Kidney Int. 79:599–612. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wilde B, Thewissen M, Damoiseaux J, van
Paassen P, Witzke O and Tervaert JW: T cells in ANCA-associated
vasculitis: what can we learn from lesional versus circulating T
cells? Arthritis Res Ther. 12:2042010. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brouwer E, Tervaert JW, Horst G, et al:
Predominance of IgG1 and IgG4 subclasses of anti-neutrophil
cytoplasmic autoantibodies (ANCA) in patients with Wegener’s
granulomatosis and clinically related disorders. Clin Exp Immunol.
83:379–386. 1991.PubMed/NCBI
|
|
4
|
Wilde B, van Paassen P, Damoiseaux J, et
al: Dendritic cells in renal biopsies of patients with
ANCA-associated vasculitis. Nephrol Dial Transplant. 24:2151–2156.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lamprecht P, Moosig F, Csernok E, et al:
CD28 negative T cells are enriched in granulomatous lesions of the
respiratory tract in Wegener’s granulomatosis. Thorax. 56:751–757.
2001.PubMed/NCBI
|
|
6
|
Lamprecht P, Csernok E and Gross WL:
Effector memory T cells as driving force of granuloma formation and
autoimmunity in Wegener’s granulomatosis. J Intern Med.
260:187–191. 2006.PubMed/NCBI
|
|
7
|
Wilde B, Thewissen M, Damoiseaux J, et al:
Th17 expansion in granulomatosis with polyangiitis (Wegener’s): the
role of disease activity, immune regulation and therapy. Arthritis
Res Ther. 14:R2272012.PubMed/NCBI
|
|
8
|
Wilde B, Hua F, Dolff S, et al: Aberrant
expression of the negative costimulator PD-1 on T cells in
granulomatosis with polyangiitis. Rheumatology. 51:1188–1197. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wilde B, Dolff S, Cai X, et al:
CD4+CD25+ T-cell populations expressing CD134
and GITR are associated with disease activity in patients with
Wegener’s granulomatosis. Nephrol Dial Transplant. 24:161–171.
2009.PubMed/NCBI
|
|
10
|
Stegeman CA, Tervaert JW, Huitema MG and
Kallenberg CG: Serum markers of T cell activation in relapses of
Wegener’s granulomatosis. Clin Exp Immunol. 91:415–420. 1993.
|
|
11
|
Popa ER, Stegeman CA, Bos NA, Kallenberg
CG and Tervaert JW: Differential B- and T-cell activation in
Wegener’s granulomatosis. J Allergy Clin Immunol. 103:885–894.
1999.PubMed/NCBI
|
|
12
|
Marinaki S, Kälsch AI, Grimminger P, et
al: Persistent T-cell activation and clinical correlations in
patients with ANCA-associated systemic vasculitis. Nephrol Dial
Transplant. 21:1825–1832. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Abdulahad WH, Stegeman CA, van der Geld
YM, Doornbos-van der Meer B, Limburg PC and Kallenberg CG:
Functional defect of circulating regulatory CD4+ T cells
in patients with Wegener’s granulomatosis in remission. Arthritis
Rheum. 56:2080–2091. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Free ME, Bunch DO, McGregor JA, et al:
ANCA-associated vasculitis patients have defective Treg function
exacerbated by presence of a suppression-resistant effector
population. Arthritis Rheum. 65:1922–1933. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
O’Shea JJ and Plenge R: JAK and STAT
signaling molecules in immunoregulation and immune-mediated
disease. Immunity. 36:542–550. 2012.PubMed/NCBI
|
|
16
|
Stark GR and Darnell J Jr: The JAK-STAT
pathway at twenty. Immunity. 36:503–514. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liao W, Lin JX and Leonard WJ:
Interleukin-2 at the crossroads of effector responses, tolerance,
and immunotherapy. Immunity. 38:13–25. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang XP, Ghoreschi K, Steward-Tharp SM, et
al: Opposing regulation of the locus encoding IL-17 through direct,
reciprocal actions of STAT3 and STAT5. Nat Immunol. 12:247–254.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lovato P, Brender C, Agnholt J, et al:
Constitutive STAT3 activation in intestinal T cells from patients
with Crohn’s disease. J Biol Chem. 278:16777–16781. 2003.PubMed/NCBI
|
|
20
|
Durant L, Watford WT, Ramos HL, et al:
Diverse targets of the transcription factor STAT3 contribute to T
cell pathogenicity and homeostasis. Immunity. 32:605–615. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Engelhardt KR, Shah N, Faizura-Yeop I, et
al: Clinical outcome in IL-10- and IL-10 receptor-deficient
patients with or without hematopoietic stem cell transplantation. J
Allergy Clin Immunol. 131:825–830. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hellmich B, Flossmann O, Gross WL, et al:
EULAR recommendations for conducting clinical studies and/or
clinical trials in systemic vasculitis: focus on anti-neutrophil
cytoplasm antibody-associated vasculitis. Ann Rheum Dis.
66:605–617. 2007. View Article : Google Scholar
|
|
23
|
Leavitt RY, Fauci AS, Bloch DA, et al: The
American College of Rheumatology 1990 criteria for the
classification of Wegener’s granulomatosis. Arthritis Rheum.
33:1101–1107. 1990.PubMed/NCBI
|
|
24
|
Jennette JC, Falk RJ, Andrassy K, et al:
Nomenclature of systemic vasculitides. Proposal of an international
consensus conference. Arthritis Rheum. 37:187–192. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jennette JC, Falk RJ, Bacon PA, et al:
2012 revised International Chapel Hill Consensus Conference
Nomenclature of Vasculitides. Arthritis Rheum. 65:1–11. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Far DF, Peyron JF, Imbert V and Rossi B:
Immunofluorescent quantification of tyrosine phosphorylation of
cellular proteins in whole cells by flow cytometry. Cytometry.
15:327–334. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Morgan MD, Day CJ, Piper KP, et al:
Patients with Wegener’s granulomatosis demonstrate a relative
deficiency and functional impairment of T-regulatory cells.
Immunology. 130:64–73. 2010.
|
|
28
|
Marinaki S, Neumann I, Kälsch AI, et al:
Abnormalities of CD4 T cell subpopulations in ANCA-associated
vasculitis. Clin Exp Immunol. 140:181–191. 2005. View Article : Google Scholar : PubMed/NCBI
|
